Blouse Grant E.'s Form 4 filing
Gyre Therapeutics, Inc. (GYRE) · filed Aug 10, 2022
- Accession no.
- 0001209191-22-045251
- Filed
- Aug 10, 2022, 5:17 PM ET
- Trade date
- Aug 9, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $1.53K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blouse Grant E.CIK 0001869883 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 | Common Stock | PPurchaseAcquired | +3,250 | $0.47 | +$1,527.5 | 9,417 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.